We are live on ! Find out more
CLLS

Cellectis

31 hedge funds and large institutions have $26.1M invested in Cellectis in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0.05% less ownership

Funds ownership: 13.79%13.73% (-0.05%)

9% less funds holding

Funds holding: 3431 (-3)

14% less capital invested

Capital invested by funds: $30.5M → $26.1M (-$4.35M)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

79% less call options, than puts

Call options by funds: $17K | Put options by funds: $82K

Holders
31
Holders Change
-3
Holders Change %
-8.82%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
6
Closed
5
Calls
$17K
Puts
$82K
Net Calls
-$65K
Net Calls Change
-$88K

CLLS Hedge Fund Activity: Q1 2024 in Review

31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2024, worth a combined $26.1M — down 14% from $30.5M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CLLS and 3 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Principal Financial Group, adding an estimated $68.9K. The largest seller was Morgan Stanley, cutting an estimated $189K.

  • 31 institutional investors held Cellectis (CLLS) as of Q1 2024, down from 34 in Q4 2023.
  • Funds reported $26.1M of Cellectis stock for Q1 2024, down 14% quarter-over-quarter.
  • 3 funds opened new Cellectis positions in Q1 2024 and 5 closed out, a net change of -2 holders.
  • The largest Cellectis buyer in Q1 2024 was Principal Financial Group, an estimated $68.9K added.
  • The largest Cellectis seller in Q1 2024 was Morgan Stanley, an estimated $189K sold.

Based on aggregated 13F filings for Q1 2024.